HMDCF (HUTCHMED (China)) Other Long-Term Liabilities: $109.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HMDCF HUTCHMED (China) Ltd HMDCF
68 GF Score
Price $2.16
GF Value $2.63
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is HUTCHMED (China) Other Long-Term Liabilities?

HUTCHMED (China) HMDCF 68 Other Long-Term Liabilities is $109.7 Mil as of Dec. 2025. GuruFocus rates HMDCF with a GF Score™ of 68/100 and a GF Value™ of $2.63 (Modestly Undervalued). The stock has 8 warning signs investors should review.

HUTCHMED (China)'s other long-term liabilities for the quarter that ended in Dec. 2025 was $109.7 Mil.

HUTCHMED (China)'s quarterly other long-term liabilities increased from Dec. 2024 ($55.6 Mil) to Jun. 2025 ($98.2 Mil) and increased from Jun. 2025 ($98.2 Mil) to Dec. 2025 ($109.7 Mil).

HUTCHMED (China)'s annual other long-term liabilities declined from Dec. 2023 ($82.3 Mil) to Dec. 2024 ($55.6 Mil) but then increased from Dec. 2024 ($55.6 Mil) to Dec. 2025 ($109.7 Mil).

HUTCHMED (China) Other Long-Term Liabilities Related Terms

HUTCHMED (China) Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for HUTCHMED (China)'s Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HUTCHMED (China) Other Long-Term Liabilities Chart

HUTCHMED (China) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.33 15.37 82.31 55.64 109.69

HUTCHMED (China) Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.31 79.93 55.64 98.16 109.69
HMDCF
68GF Score
HUTCHMED (China) Ltd HMDCF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HUTCHMED (China) Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $109.7 Mil mean?
HUTCHMED (China) (HMDCF) has a Other Long-Term Liabilities of $109.7 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on HUTCHMED (China) and its competitors.
Is HUTCHMED (China)'s Other Long-Term Liabilities too high?
HUTCHMED (China)'s current Other Long-Term Liabilities is $109.7 Mil. Overall, HUTCHMED (China) has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HUTCHMED (China)'s Other Long-Term Liabilities compare to ZTS and UTHR?
HUTCHMED (China)'s Other Long-Term Liabilities of $109.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on HUTCHMED (China) and its competitors. HUTCHMED (China)'s current Other Long-Term Liabilities is $109.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HUTCHMED (China) stock overvalued right now?
Based on GuruFocus' analysis, HUTCHMED (China) (HMDCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.63, compared to a current price of $2.16 — trading 17.9% below its estimated fair value. The current Other Long-Term Liabilities is $109.7 Mil. HUTCHMED (China)'s overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For HUTCHMED (China) (HMDCF), the current Other Long-Term Liabilities is $109.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HUTCHMED (China) (HMDCF) Overvalued in 2026?

Based on GuruFocus' analysis, HUTCHMED (China) stock appears to be undervalued. The current stock price of $2.16 is trading 17.9% below its estimated GF Value™ of $2.63. GuruFocus considers HUTCHMED (China) to be Modestly Undervalued.

Key valuation signals for HMDCF:

  • Other Long-Term Liabilities: $109.7 Mil
  • GF Value™: $2.63 vs. price of $2.16 (17.9% below fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the HMDCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HUTCHMED (China) Business Description

Address 2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
68GF Score

Get the complete analysis for HMDCF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.16
Price
$2.63
GF Value